Genericart Metformin+Voglibose 500mg/0.2mg Tablet SR
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview Genericart Metformin+Voglibose 500mg/0.2mg Tablet SR
Metformin and Voglibose 500mg/0.2mg extended-release tablets (Genericart) are antidiabetic medications used together to manage type 2 diabetes in adults. This combination therapy helps regulate blood glucose. Take this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can increase blood sugar levels, risking complications like kidney damage, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Potential side effects include nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin rash. These are usually transient and resolve spontaneously. Persistent or concerning side effects warrant medical attention. Your doctor can offer strategies to manage or treat bothersome side effects. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their doctor before starting this medication. Pregnant or breastfeeding women require medical consultation before use. Regular blood glucose monitoring is necessary, and your physician may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Genericart Metformin+Voglibose 500mg/0.2mg Tablet SR
No text provided. Please provide the text you wish to be rewritten.
Uses of Genericart Metformin+Voglibose 500mg/0.2mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Genericart Metformin+Voglibose 500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Genericart Metformin+Voglibose 500mg/0.2mg SR Tablets. Ingest the tablets whole; do not chew, crush, or divide them. Always take this medication with food.
Common Side effects of Genericart Metformin+Voglibose 500mg/0.2mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Genericart Metformin+Voglibose 500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Genericart Metformin+Voglibose 500mg/0.2mg Extended-Release tablets should be administered with meals.
How Genericart Metformin+Voglibose 500mg/0.2mg Tablet SR works:
Metformin and Voglibose 500mg/0.2mg Extended-Release tablets (Genericart brand) offer a dual-action approach to diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Genericart Metformin+Voglibose 500mg/0.2mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The combination medication Metformin and Voglibose (Genericart 500mg/0.2mg SR tablets) may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers before recommending its use. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Metformin and Voglibose (Genericart 500mg/0.2mg SR tablets) likely pose a risk during lactation. Scant evidence from human studies indicates potential transfer to breast milk, possibly causing infant harm.
DrivingSAFE
Metformin and Voglibose (Genericart 500mg/0.2mg SR tablets) typically have no impact on driving ability. Nevertheless, individuals taking this combination should be aware of the increased hypoglycemia risk when used alongside other diabetes medications like sulfonylureas, insulin, or repaglinide.
KidneyCAUTION
Metformin and Voglibose tablets (500mg/0.2mg sustained-release) require careful use in individuals with kidney impairment. Dosage modification may be necessary. Physician consultation is recommended. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Genericart Metformin/Voglibose 500mg/0.2mg extended-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Genericart Metformin+Voglibose 500mg/0.2mg Tablet SR :
Should you forget a dose of your Genericart Metformin+Voglibose 500mg/0.2mg SR tablet, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Genericart Metformin+Voglibose 500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently